产次与β-淀粉样蛋白对绝经后女性认知及海马体积的影响
本研究基于ALFA+观察队列,纳入254名认知未受损的绝经后女性,随访约3.38年,分析产次与淀粉样蛋白状态对认知下降和海马体积的交互作用。结果显示,在淀粉样蛋白阳性女性中,较高产次与更陡的认知下降(β=-0.035,95%CI -0.068至-0.003,p=0.033)和更低的海马体积(β=-0.134,95%CI -0.263至-0.005,p=0.036)相关。提示产次可能影响临床前AD阶段对AD病理的韧性。
要点
- 在淀粉样蛋白阳性的认知未受损绝经后女性中,高产次与更快的认知下降相关。
- 淀粉样蛋白阳性女性中,高产次与随访期间更低的海马体积相关。
- 产次可能调节临床前阿尔茨海默病阶段对AD病理的韧性。
核心结论
- 在认知未受损的绝经后女性中,较高产次与AD病理交互影响认知下降和海马体积减少。
- 产次可能影响临床前AD阶段对AD病理的韧性。
研究设计与样本
- 基于ALFA+观察队列的认知未受损绝经后女性分析
- 纳入254名女性,完成1或2次访视,间隔约3年(均值3.38,SD 0.55)
- 收集生殖数据、认知测试(改良临床前阿尔茨海默认知复合量表)、脑脊液生物标志物(Aβ42和Aβ40)及结构MRI
- 采用线性混合效应模型分析产次、时间和Aβ状态(基于脑脊液Aβ42/Aβ40)对认知和海马体积的交互效应
- 协变量包括APOE-ε4状态、年龄和总颅内体积
主要发现
- 产次与Aβ状态对认知下降和海马体积存在显著交互作用。
- 在淀粉样蛋白阳性女性中,较高产次与更陡的认知下降相关(β=-0.035,95%CI -0.068至-0.003,p=0.033)。
- 在淀粉样蛋白阳性女性中,较高产次与各时间点更低的海马体积相关(β=-0.134,95%CI -0.263至-0.005,p=0.036)。
临床怎么用
- 对于认知未受损的绝经后女性,尤其淀粉样蛋白阳性者,产次可能作为评估AD病理韧性的参考因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Epidemiologic studies exploring the effect of parity on Alzheimer disease (AD) yield mixed results, and little is known about how parity may modify the impact of AD pathology on brain and cognitive aging. We examined the effect of parity and AD pathology on hippocampal volume (HV) and cognitive changes in cognitively unimpaired (CU) postmenopausal women. METHODS: Analysis was performed on CU postmenopausal women from the ALFA+ observational cohort based in the BarcelonaBeta Brain research center, who completed 1 or 2 visits spaced by ∼3 years (mean = 3.38, SD = 0.55) with reproductive data, cognitive testing (modified Preclinical Alzheimer's Cognitive Composite), CSF biomarkers (Aβ42 and Aβ40), and structural MRI. We used linear mixed-effects models to investigate the interactive effects of parity, time, and Aβ status (based on CSF Aβ42/Aβ40) on cognition and HV. APOE-ε4 status, age, and total intracranial volume were included as covariates. RESULTS: A total of 254 women were included in our analyses ranging from 49.2 to 73.4 years (mean age = 61.2) at visit 1. A significant interaction between parity and Aβ status was observed for cognitive decline and HV. In women with positive amyloid status, higher parity was associated with steeper cognitive decline (β = -0.035, 95% CI -0.068 to -0.003, p = 0.033) and lower HV across time points (β = -0.134, 95% CI -0.263 to -0.005, p = 0.036). DISCUSSION: In CU postmenopausal women, higher parity interacts with AD pathology to influence cognitive decline and HV reductions. These findings suggest that parity may affect resilience to AD pathology in preclinical AD stages.
引用
- Gallay C, Soldevila-Domenech N, López-Martos D, et al. Effect of Parity and β-Amyloid on Cognition and Hippocampal Volume in Postmenopausal Women. Neurology. 2026. PMID: 42330435. doi:10.1212/WNL.0000000000218153
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。